Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06463119 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT06463119 · ClinicalTrials.gov record · last posted 2024-11-07

Registry of Vaccine Responses in Immune Compromised Patients

Name: Registry of Vaccine Responses in Immune Compromised Patients — clinical trial record (NCT06463119)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: REVAPI

StatusRecruiting

PhaseNot specified

SponsorLaure Pittet, MD-PhD

Started2024-09-24

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

The aim of this project is to monitor, guide and document vaccination, vaccine responses, persistence of protection, vaccine efficacy and safety in immune compromised patients at various moment of their disease: right after the diagnosis, before the introduction of the immunosuppressive treatment, once the individual is under immunosuppressive treatment, or once immunosuppression is over.

Amendment record 1 amendment on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended once since 2024-06-12. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

Trial Details

NCT Number	NCT06463119
Lead Sponsor	Laure Pittet, MD-PhD
Conditions	Immunosuppression
Enrollment	300 participants
Start Date	2024-09-24
Primary Completion	2029-04 (estimated)
Study Completion	2029-04 (estimated)
Updated on ClinicalTrials.gov	2024-11-07